Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Ghesani
Response to Anti-Pd1 Therapy With Nivolumab in Metastatic Sarcomas
Clinical Sarcoma Research
Oncology
Related publications
Response and Outcomes After Anti-Ctla4 Versus Anti-Pd1 Combined With Stereotactic Body Radiation Therapy for Metastatic Non-Small Cell Lung Cancer: Retrospective Analysis of Two Single-Institution Prospective Trials
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Targeting Tumor-Intrinsic Hexosamine Biosynthesis Sensitizes Pancreatic Cancer to Anti-Pd1 Therapy
Journal of Clinical Investigation
Medicine
Response to Nivolumab in Metastatic Collecting Duct Carcinoma Expressing PD‑L1: A Case Report
Molecular and Clinical Oncology
Cancer Research
Oncology
Targeting PIM Kinase With PD1 Inhibition Improves Immunotherapeutic Anti-Tumor T Cell Response
Clinical Cancer Research
Cancer Research
Oncology
Tumoral EHF Predicts the Efficacy of Anti-Pd1 Therapy in Pancreatic Ductal Adenocarcinoma
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab
Clinical Genitourinary Cancer
Oncology
Urology
Anti-Pd1 in the Wonder-Gut-Land
Cell Research
Cell Biology
Molecular Biology
Photodynamic Therapy With Acridine Orange in Musculoskeletal Sarcomas
The Journal of Bone and Joint Surgery. British volume
Vitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma
Frontiers in Oncology
Cancer Research
Oncology
